A primary biliary cholangitis (PBC) diagnosis can be life-changing ... PBC is a rare autoimmune disease in which the immune ...

Patients with biliary tract cancers may present with symptoms such as jaundice, dark urine, clay-colored stool, abdominal ...

Immune checkpoint inhibitors (ICI) have led to breakthrough improvements in the management of malignancy including hepatocellular (HCC) and biliary tract cancer, improving decades-old standards of ...

Yepuri, MDPrimary biliary cholangitis (PBC), also known as primary biliary cirrhosis, is a chronic and progressive disease ...

Medscape Medical News, October 29, 2024 Can We Repurpose Obesity Drugs to Reverse Liver Disease ... from the US FDA's Adverse Event Reporting System on tirzepatide showed adverse events generally ...

We're dedicated to nurturing and guiding the future generation of physicians and physician-scientists, recognizing that our trainees are the cornerstone of our nation's healthcare system. Since ...

Park (65, male), who recently retired after working for more than 30 years, continued to live a healthy life, enjoying ...

The FDA has approved a new drug, zanidatamab, for adults with advanced biliary tract cancer ... or bile duct (branched tubes connecting the liver and gall bladder to the small intestine ...

is one of the most common causes of neonatal cholestasis and accounts for over half of children who undergo liver transplantation. In biliary atresia, a number of prenatal or perinatal insults to ...

Biliary-tract obstruction resulting from carcinoma arising in the bile ducts was relieved for eight months, and the patient survived for thirteen months. The left lobe of the liver, a portion of ...

Biliary tract cancers are uncommon and aggressive tumors that affect the ducts and organs that make and store bile and release it into the small intestine to aid in digestion. This category of cancers ...

Zanidatamab-hrii received FDA accelerated approval for HER2-positive biliary tract cancer, showing a 52% objective response rate in the HERIZON-BTC-01 trial. Biliary tract cancers represent 3% of ...